NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Anti-Infectives



Research on anti-infectives described by scientists at Emory University, Medical Department



January 15th, 2008

"Fumagillin is an active amebicide and anti-infective isolated from the fungus Aspergillus fumigatus," scientists in the United States report.

"Since its characterization in 1951, fumagillin has been studied extensively for its anti-infective properties. Although fumagillin is not approved for systemic use in the USA, this compound has one of the highest efficacies for the treatment of microsporidial infections in HIV-positive patients," wrote B. Lefkove and colleagues, Emory University, Medical Department.

The researchers concluded: "Fumagillin does exhibit some side effects that have deterred its acceptance as a viable treatment, but the current...


Source: Cancer Weekly (2008-01-15)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login